Knockout of SETDB1 gene using the CRISPR/cas-9 system increases migration and transforming activities via complex

Han-Heom Na1, Sungjin Moon1, Keun-Cheol Kim1

  • 1Department of Biological Sciences, College of Natural Sciences, Kangwon National University, Chuncheon, 24341, Republic of Korea.

Insights

SETDB1 gene knockout in lung cancer cells increases migration and transforming activity by downregulating E-cadherin and β-catenin. SETDB1 regulates key proteins involved in cancer progression.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Molecular Biology

Background:

  • SETDB1 (SET Domain Bifunctional Histone Demethylase 1) is involved in epigenetic transcriptional regulation.
  • SETDB1 expression decreases with anticancer drug treatment, but its functional significance remains unclear.
  • CRISPR/Cas9 gene editing is a powerful tool for investigating gene function.

Purpose of the Study:

  • To investigate the functional significance of SETDB1 downregulation in human lung cancer cells.
  • To analyze molecular changes in A549 lung cancer cells following SETDB1 knockout (KO).
  • To explore the role of SETDB1 in regulating cell proliferation, migration, and transformation.

Main Methods:

  • Generated SETDB1-knockout A549 human lung cancer cells using the CRISPR/Cas9 system.
  • Compared proliferation, doxorubicin sensitivity, migration, and transforming activity between wild-type and SETDB1-KO cells.
  • Utilized Western blot, immunostaining, qPCR, and RT-PCR to analyze gene and protein expression, including E-cadherin, β-catenin, STAT3, and Akt.

Main Results:

  • SETDB1-KO cells showed slightly decreased proliferation but no significant change in doxorubicin sensitivity.
  • Migration and transforming activities were dramatically increased in SETDB1-KO cells.
  • SETDB1-KO led to downregulation of E-cadherin and β-catenin, with altered E-cadherin localization. Total STAT3 and Akt levels increased, but STAT3 activation (pSTAT3) was not induced by doxorubicin.
  • SETDB1 re-expression restored E-cadherin, β-catenin, STAT3, and Akt levels.

Conclusions:

  • SETDB1 plays a crucial role in regulating E-cadherin, β-catenin, STAT3, and Akt expression in lung cancer cells.
  • SETDB1 downregulation correlates with increased cell migration and transforming activity.
  • These findings highlight SETDB1 as a potential therapeutic target in lung cancer.